Plymouth, MN – February 3, 2015 – Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE:CMN) has launched a new aerosol-based bio-decontamination system, the MINNCARE DRY FOG® 2, the latest evolution of Mar Cor’s Dry Fog Technology and an integral part of modern clean room disinfection procedures. Aimed specifically at the cleanroom industry, the new and improved system is designed completely of 316 L stainless steel and features a robust construction that is engineered to be durable and virtually maintenance free. The new design also features a multi-directional spray apparatus that allows for eight different nozzle(s) positions increasing the coverage possibilities for higher flexibility.
Christopher Fournier, VP Marketing, noted, “The new system delivers many new features that increase the coverage and flexibility of our dry fog technology. The redesigned distribution mechanism allows for spray diffusion that is horizontal or vertical, while linking capability permits decontamination of multiple linked rooms simultaneously. These features come with the 100% autoclavable design, short process time, and optimal efficacy that has historically been associated with Dry Fog Technology and MINNCARE® Cold Sterilant. These improvements will allow the end user to improve the efficiency of their clean room disinfection procedures, utilizing the Dry Fog 2 system in conjunction with traditional disinfection procedures.” MINNCARE® and MINNCARE DRY FOG® are registered trademarks of Medivators Inc. (a Cantel Medical Company)
MINNCARE® is a registered trademark of Medivators Inc. (a Cantel Medical Company)
About Cantel Medical Corp.
Cantel Medical Corp. (NYS: CMN) Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products. For further information, visit the Cantel website at www.cantelmedical.com
Mar Cor Purification, Inc.,a wholly-owned subsidiary of Cantel Medical Corp. (NYSE: CMN), is a water purification company and is the largest supplier of dialysis medical water systems in North America. It has service facilities in 30 cities in the United States and Canada including nine ion exchange resin regeneration plants strategically located in large metropolitan areas. Mar Cor also provides turnkey water purification systems to high purity clients including pharmaceutical, cosmetics, semiconductor and other bacteria controlled applications. Unique hollow fiber filtration/separation products and Peracetic acid (PAA) disinfectants are provided through a worldwide distributor network.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel’s filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
SOURCE: Mar Cor Purification